Download
annalsats.202104-520oc.pdf 720,46KB
WeightNameValue
1000 Titel
  • Post-Intensive Care Unit Syndrome in a Cohort of COVID-19 Survivors in New York City
1000 Autor/in
  1. Weidman, Karissa |
  2. LaFond, Elyse |
  3. Hoffman, Katherine L. |
  4. Goyal, Parag |
  5. Parkhurst, Christopher N. |
  6. Derry-Vick, Heather |
  7. Schenck, Edward |
  8. Lief, Lindsay |
1000 Erscheinungsjahr 2022
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2022-07
1000 Erschienen in
1000 Quellenangabe
  • 19(7):1158-1168
1000 Copyrightjahr
  • 2022
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1513/AnnalsATS.202104-520OC |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278639/ |
1000 Ergänzendes Material
  • https://www.atsjournals.org/doi/suppl/10.1513/AnnalsATS.202104-520OC |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • RATIONALE: The coronavirus disease (COVID-19) pandemic has led to a dramatic increase in the number of survivors of critical illness. These survivors are at increased risk for physical, psychological, and cognitive impairments known collectively as post-intensive care syndrome (PICS). Little is known about the prevalence of PICS in COVID-19 survivors. OBJECTIVES: To report the prevalence of physical, psychological, and cognitive impairment among COVID-19 intensive care unit (ICU) survivors receiving follow-up care in an ICU recovery clinic, to assess for associations between PICS and ICU-related factors, and to compare the cohort of ICU survivors who attended a post-ICU clinic with a cohort of ICU survivors who did not. METHODS: We performed a retrospective cohort study of COVID-19 ICU survivors admitted from March to May 2020 who were subsequently seen in a post-ICU recovery clinic in New York City. We abstracted medical chart data on available clinical screening instruments for physical, psychological, and cognitive impairment. Associations between these outcomes and care-related variables were tested. Baseline characteristics and in-hospital treatments of the post-ICU clinic cohort were compared with those of COVID-19 ICU survivors from the same institution who were not seen in the post-ICU clinic. RESULTS: Eighty-seven COVID-19 ICU survivors were seen in our post-ICU recovery clinic. The median age was 62 years, and 74% were male. The median length of hospitalization was 51 days, and the median length of ICU stay was 22 days. At the post-ICU follow-up visit, 29%, 21%, and 13% of patients reported clinically significant levels of depressive symptoms, anxiety, and post-traumatic stress disorder symptoms, respectively. Twenty-five percent had cognitive impairment. The overall prevalence of PICS was 90%. There were no associations between length of ICU stay, delirium, and exposure to benzodiazepines, steroids, or systemic paralytics with positive screening results for physical, psychological, or cognitive impairment. Baseline characteristics and ICU-related factors were similar in the cohort of COVID-19 ICU survivors who attended the ICU recovery clinic and those who did not. CONCLUSIONS: PICS is common in COVID-19 survivors. We did not find any association with length of ICU stay or the use of benzodiazepines, steroids, or paralytics.
1000 Sacherschließung
gnd 1206347392 COVID-19
lokal intensive care
lokal acute respiratory distress syndrome
lokal post-traumatic stress disorder
lokal physical impairment
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/V2VpZG1hbiwgS2FyaXNzYQ==|https://frl.publisso.de/adhoc/uri/TGFGb25kLCBFbHlzZQ==|https://frl.publisso.de/adhoc/uri/SG9mZm1hbiwgS2F0aGVyaW5lIEwu|https://frl.publisso.de/adhoc/uri/R295YWwsIFBhcmFn|https://frl.publisso.de/adhoc/uri/UGFya2h1cnN0LCBDaHJpc3RvcGhlciBOLg==|https://orcid.org/0000-0003-0753-0859|https://orcid.org/0000-0002-7950-5989|https://frl.publisso.de/adhoc/uri/TGllZiwgTGluZHNheQ==
1000 Label
1000 Förderer
  1. Center for Strategic Scientific Initiatives, National Cancer Institute |
  2. National Institutes of Health |
1000 Fördernummer
  1. K99 CA245488
  2. K23HL151876
1000 Förderprogramm
  1. -
  2. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Center for Strategic Scientific Initiatives, National Cancer Institute |
    1000 Förderprogramm -
    1000 Fördernummer K99 CA245488
  2. 1000 joinedFunding-child
    1000 Förderer National Institutes of Health |
    1000 Förderprogramm -
    1000 Fördernummer K23HL151876
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6435597.rdf
1000 Erstellt am 2022-10-19T17:07:07.735+0200
1000 Erstellt von 329
1000 beschreibt frl:6435597
1000 Bearbeitet von 25
1000 Zuletzt bearbeitet 2023-10-20T13:25:15.409+0200
1000 Objekt bearb. Thu Apr 27 12:36:59 CEST 2023
1000 Vgl. frl:6435597
1000 Oai Id
  1. oai:frl.publisso.de:frl:6435597 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source